The American Cancer Society estimates that 147,950 people will be diagnosed with colorectal cancer and 53,200 could die from this disease in 2020.
Colorectal cancer (cancer that starts in the colon or rectum) is the third most commonly diagnosed form of cancer. On average, the lifetime risk of developing colon cancer is about one in 23 for men and women combined (4.5%), however, this varies widely according to individual risk factors. It is also the second leading cause of cancer death in men and women combined in the United States.
Medicom Health’s Colorectal Cancer HRA is the perfect tool to educate consumers on screening options and direct them to your clinicians for care. This evidence-based HRA estimates the user’s lifetime risk for colorectal cancer – taking lifestyle, genetics and personal health history into consideration.
This disease takes the lives of more than 50,000 people every year, but Colorectal cancer is highly treatable if discovered early!
Talk to your Client Success Team member to learn more today! Together, we can provide education on how to prevent this disease and lower the statistics. Early detection can save lives.
Colon Cancer and Age:
- The median diagnosis age for colon cancer is 68 in men and 72 in women; for rectal cancer it is 63 years of age in both men and women.
- As a result of rising colon and rectal cancer incidence rates in younger age groups coincident with declining rates in older age groups, the proportion of cases diagnosed in individuals 50 and younger increased from 6% in 1990 to 11% in 2013.
- Most of these cases (72%) occur in people who are in their 40s.